Myelodysplastic Myeloproliferative Neoplasms
📧 Sign up to get email alerts when something new happens for Myelodysplastic Myeloproliferative Neoplasms.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-10-25Clinical Trial Update: Donor Bone Marrow Transplant in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders [Phase 2]
A Phase 2 clinical trial evaluating donor bone marrow transplantation for various hematologic diseases has completed.
-
CLINICAL_TRIALS withdrawal · 2012-10-02Clinical Trial Update: Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 study of busulfan and fludarabine conditioning before donor stem cell transplant for hematologic cancers has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2012-10-01Clinical Trial Update: Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer [Phase 2]
Phase 2 trial evaluating early administration of anti-thymocyte globulin (ATG) followed by cyclophosphamide, busulfan and fludarabine as a c…
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer [NA]
A clinical trial comparing moxifloxacin with ciprofloxacin plus amoxicillin for fever and neutropenia in cancer patients was terminated.
-
CLINICAL_TRIALS trial_result · 2012-06-19Clinical Trial Update: Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 trial investigating donor stem cell or donor white blood cell infusions in hematologic cancers; the study is terminated with results…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-05-28Clinical Trial Update: G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders [NA]
Clinical trial update for a study evaluating G-CSF–treated donor bone marrow transplant in hematologic disorders; the trial (NCT00253552) is…
-
CLINICAL_TRIALS trial_result · 2012-03-08Clinical Trial Update: T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic Malignancies [Phase 1]
Phase 1 trial assessing T-cell-depleted allogeneic stem cell transplantation after immunoablative induction chemotherapy and reduced-intensi…
-
CLINICAL_TRIALS trial_result · 2011-12-08Clinical Trial Update: Non-Ablative Allo HSCT For Hematologic Malignancies or SAA [Phase 2]
Phase 2 trial update evaluating non-ablative allogeneic hematopoietic stem cell transplantation for hematologic malignancies and severe apla…
-
CLINICAL_TRIALS trial_result · 2011-07-15Clinical Trial Update: Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluated sirolimus, tacrolimus, and methotrexate to prevent acute graft-versus-host disease in patients with he…
-
CLINICAL_TRIALS trial_result · 2011-07-13Clinical Trial Update: A Web-Based Stem Cell Transplant Support System or Standard Care in Young Patients Undergoing Stem Cell Transplant and Their Families [Phase 3]
Phase 3 trial comparing a web-based stem cell transplant support system to standard care in young patients undergoing stem cell transplant a…
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: FR901228 in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 clinical trial evaluating romidepsin (FR901228) in patients with myelodysplastic syndromes, acute myeloid leukemia, or non-Hodgkin l…
-
CLINICAL_TRIALS trial_result · 2011-03-07Clinical Trial Update: Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders [Phase 2]
Completed Phase 2 study evaluating donor umbilical cord blood transplantation for patients with leukemia, lymphoma, and certain nonmalignant…
-
CLINICAL_TRIALS trial_result · 2010-09-21Clinical Trial Update: Total-Body Irradiation, Cyclophosphamide, and Stem Cell Transplantation in Treating Patients With Hematologic Cancer [Phase 1]
A Phase 1 clinical trial evaluates total-body irradiation with cyclophosphamide and stem cell transplantation in patients with hematologic c…
-
CLINICAL_TRIALS trial_result · 2010-09-16Clinical Trial Update: Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Myeloproliferative Disorder [Phase 1, Phase 2]
Phase 1/2 clinical trial update on donor peripheral stem cell transplantation for patients with acute myeloid leukemia, myelodysplastic synd…
-
CLINICAL_TRIALS trial_result · 2010-09-15Clinical Trial Update: Anti-Thymocyte Globulin and Etanercept in Treating Patients With Myelodysplastic Syndromes [Phase 2]
A Phase 2 clinical trial evaluating anti-thymocyte globulin and etanercept for myelodysplastic syndromes has completed.
-
CLINICAL_TRIALS trial_result · 2010-06-11Clinical Trial Update: High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer [Phase 2]
A Phase 2 trial evaluating high-dose chemotherapy followed by peripheral stem cell transplantation for hematologic cancers has completed.
-
CLINICAL_TRIALS research · 2010-04-13Clinical Trial Update: Low-Dose Decitabine Compared With Standard Supportive Care in Treating Older Patients With Myelodysplastic Syndrome [Phase 3]
This entry notes a Phase 3 trial evaluating low-dose decitabine versus standard supportive care in older patients with myelodysplastic syndr…
-
CLINICAL_TRIALS trial_result · 2010-04-02Clinical Trial Update: Combination Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloproliferative Disorders [Phase 2]
A Phase 2 trial evaluating the combination of chemotherapy with bone marrow or peripheral stem cell transplantation in patients with chronic…
-
CLINICAL_TRIALS trial_result · 2010-04-02Clinical Trial Update: Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease [Phase 2]
The document reports the completion of a Phase 2 trial evaluating umbilical cord blood transplantation in patients with hematologic cancers …
-
CLINICAL_TRIALS trial_result · 2010-03-17Clinical Trial Update: Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer [Phase 1]
Phase 1 clinical trial evaluating cyclophosphamide and/or mycophenolate mofetil with or without tacrolimus in patients undergoing donor bone…
-
CLINICAL_TRIALS trial_result · 2010-03-10Clinical Trial Update: Combination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic Cancer [Phase 1]
A Phase 1 study evaluating a combination chemotherapy regimen with infusion of leukocytes in patients with hematologic cancers, which has co…
-
CLINICAL_TRIALS trial_result · 2010-03-10Clinical Trial Update: MS-275 in Treating Patients With Hematologic Cancer [Phase 1]
A Phase 1 trial of MS-275 (entinostat) in patients with hematologic cancers, including leukemia, multiple myeloma/plasma cell neoplasms, and…
-
CLINICAL_TRIALS trial_result · 2010-03-10Clinical Trial Update: Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [Phase 1]
Phase 1 trial of cyclophosphamide followed by bone marrow transplantation for hematologic cancers has completed.
-
CLINICAL_TRIALS trial_result · 2010-01-26Clinical Trial Update: 12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder [Phase 1]
This Phase 1 trial evaluating 12-O-tetradecanoylphorbol-13-acetate in hematologic cancers and bone marrow disorders was terminated.